Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Coral-Inspired Capsule Samples Hidden Bacteria from Small Intestine

By LabMedica International staff writers
Posted on 08 Sep 2025

The gut microbiome has been linked to conditions ranging from immune disorders to mental health, yet conventional stool tests often fail to capture bacterial populations in the small intestine. More...

This region, the body’s largest mucosal surface, is crucial for host-microbiome interactions, metabolism, and immunity, but remains difficult to access. Researchers have now developed a swallowable capsule that passively collects microbes from the upper digestive tract, offering a clearer view of hidden bacterial communities missed by conventional stool tests.

The device, called the CORAL (Cellularly Organized Repeating Lattice) capsule, was developed by researchers from NYU Tandon School of Engineering (Brooklyn, NY, USA) in collaboration with NYU Abu Dhabi (Abu Dhabi, UAE). Inspired by the porous structures of marine corals, it is fabricated in a single 3D printing step and contains no moving parts, electronics, or magnets. Its design is based on mathematically defined Triply Periodic Minimal Surfaces (TPMS), forming a maze-like lattice that traps bacteria while allowing safe passage through the digestive tract.

A special coating ensures the capsule only begins sampling once it reaches the small intestine, preventing contamination from stomach acid. In animal studies, the capsule successfully captured distinct microbial populations that differed significantly from fecal samples. The findings, published in Device, showed higher levels of beneficial bacteria such as Lactobacillus, demonstrating that the capsule can reveal microbial communities missed by conventional methods.

The capsule’s simplicity and scalability make it a promising tool for microbiome research and clinical diagnostics. Unlike existing devices, it provides a non-invasive, passive method to map microbial ecosystems in situ. Researchers plan to scale the capsule to pill size, develop reliable retrieval methods, and conduct safety testing ahead of human trials.

"We designed CORAL to be as simple as possible, no batteries or electronics, just a mathematically precise structure that uses the gut's natural movement to sample bacteria," said Hanan Mohammed, lead author of the study. "It gives us access to bacterial communities that have been invisible to researchers until now."

Related Links:
NYU Tandon School of Engineering
NYU Abu Dhabi


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
Gold Member
Electrolyte Analyzer
CBS-4000 (CBS-400)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The test combines RNA signals from the tumor-immune microenvironment to predict treatment response, rather than relying on a single marker such as PD-L1 expression.(Image Credit: Adobe Stock)

RNA-Based Test Predicts Immunotherapy Response in Non-Small Cell Lung Cancer

Non-small cell lung cancer (NSCLC) represents the largest U.S. patient population eligible for immune checkpoint inhibitor therapy. Treatment selection often relies on PD-L1 expression, but a single protein... Read more

Immunology

view channel
Image Credit: Adobe Stock

Immune Profiling Identifies Early Maternal Autoantibodies Linked to Preterm Birth Risk

A typical pregnancy lasts about 40 weeks, but labor begins prematurely in roughly one in 10 pregnancies. Preterm birth is the leading cause of newborn death worldwide, yet its underlying causes and which... Read more

Industry

view channel
Image Credit: iStock

Global TB Summit Connects Diagnostic Testing With Prevention and Clinical Care

Tuberculosis remains a major global infectious disease challenge despite declining deaths. In 2024, an estimated 10.7 million people worldwide developed the disease and nearly 1.2 million died from it.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.